国产中文无码av每日更新在线观看, 亚洲天堂中文字幕一区二区三区免费, 国产口爆吞精在线观视频-黄色国产, 92福利-国内精品久久久久久99,亚洲成AV人A片不卡无码,浪潮AV无码专区,老熟女败火白浆,中文字幕日产av,色情日本免费看大片

更新于 5月23日

CHI Excellence Manager商業(yè)健康保險卓越執(zhí)行經(jīng)理

3-3.5萬
  • 上海靜安區(qū)
  • 5-10年
  • 本科
  • 全職
  • 招1人

雇員點評標簽

  • 同事很nice
  • 團隊執(zhí)行強
  • 工作環(huán)境好
  • 人際關(guān)系好
  • 氛圍活躍
  • 實力大公司

職位描述

外企
Job Summary: The CHI Landing Insight & Excellence Manager is responsible for enhancing the operational excellence of CHI (Commercial Health Insurance) projects by establishing seamless governance for the full lifecycle management of CHI projects and post-launch landing excellence. This role focuses on high-quality execution and risk management of CHI projects. The successful candidate must demonstrate a strong understanding of project management principles, innovative access strategies, and the ability to collaborate effectively with internal and external stakeholders. Responsibilities: ● Drive CHI Operation Excellence through Seamless Governance ● Drive and coordinate cross-functional teams to develop, update and optimize CHI SOP and other governance documents. Ensure the governance frameworks are aligned with industry’s best practices and organizational objectives. ● Analyze to identify inefficiencies, bottlenecks, and areas for improvement, and optimize project process to streamline operations and enhance overall project efficiency. ● Provide insights and recommendations based on project execution data and industry trends. ● Support key Market Access/Innovative Access strategy projects ● Ensure CHI Project Execution Excellence and maximize business impact on key projects ● Implement the CHI project risk grading management system to achieve full lifecycle management of CHI SOP ● Algn risk management Align risk management practices with CHI SOPs to ensure consistency and effectiveness, and collaborate with cross-functional teams on risk monitoring and response Mechanisms ● Liaise with Third-Party Administrators (TPAs) to manage the execution and follow-up of CHI projects at post-launch stage ● Monitor project milestones and deliverables and provide progress reports to internal stakeholders ● Closely work with insurers towards innovative CHI projects by understanding industry best practices. Education and Experience: ● 6+ years’ experience in insurance company, TPA or related department in MNC. ● Project Management Expertise: Strong understanding of project management principles and methodologies. ● Innovative Access Knowledge: Familiarity with innovative access strategies and market access initiatives. ● Analytical Abilities: Strong analytical skills to identify inefficiencies and drive process improvements. ● Demonstrated ability to work effectively across cultures and the agility to deliver results quickly in new and unfamiliar situations. ● Good understanding in social and commercial payer system and market dynamic. Technical Skills Requirements: ● Communication and Impact – Excellent presentation and some influencing skill ability to interact with key decision maker internally and externally. Ability to use influencing skills to make advantage in listing and scheme designing. ● Program management – Excellent ability to review and use data to develop insights and support decisions ● Business development – Explore HQ and local insurance company resources to develop potential programs Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates. Market Access #LI-PFE

工作地點

上海靜安區(qū)中信泰富廣場

職位發(fā)布者

劉一飛/人事經(jīng)理

剛剛活躍
立即溝通
公司Logo輝瑞投資有限公司公司標簽
輝瑞公司(Pfizer Inc.)創(chuàng)建于1849年,總部位于美國紐約,是一家以科學為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。輝瑞的使命是“為患者帶來改變其生活的突破創(chuàng)新”。在輝瑞,我們通過科學和全球資源為人們提供治療方案,以延長其生命,顯著改善其生活。在醫(yī)療衛(wèi)生產(chǎn)品的探索、研發(fā)和生產(chǎn)過程中,輝瑞始終致力于奉行嚴格的質(zhì)量、安全和價值標準。我們在全球的產(chǎn)品組合包括創(chuàng)新藥品和疫苗。每天,輝瑞在發(fā)達和新興市場的員工都在推進人類健康,推動疾病的預(yù)防、治療和治愈,以應(yīng)對挑戰(zhàn)我們這個時代的頑疾。輝瑞還與醫(yī)療衛(wèi)生服務(wù)方、政府和社區(qū)合作,支持并促進世界各地的人們能夠獲得更為可靠和可承付的醫(yī)療衛(wèi)生服務(wù)。這與輝瑞作為一家全球卓越的創(chuàng)新生物制藥公司的責任是一致的。170余年來,輝瑞一直致力于為所有依賴我們的人帶來改變。輝瑞于1989年進入中國市場。扎根中國30余年,輝瑞已成為在華主要的外資制藥公司之一。2021年是輝瑞新征程的開始。迄今已有170余年歷史的輝瑞正在邁入全新時代,成為一家以科學為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。目前輝瑞在中國業(yè)務(wù)覆蓋全國300余個城市,累計投資超過15億美元,并設(shè)立了1家先進的生產(chǎn)設(shè)施,2個研發(fā)中心(分別位于上海張江高科技園區(qū)和武漢光谷),在華有近7,000名員工分布于業(yè)務(wù)、研發(fā)和生產(chǎn)等領(lǐng)域。輝瑞在華上市了五大領(lǐng)域的高品質(zhì)創(chuàng)新產(chǎn)品,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見病等多個領(lǐng)域的處方藥和疫苗,強大完善的產(chǎn)品線旨在滿足生命各階段的健康需求。
公司主頁